Authors: Mansour, T Vainshtein, A

Citation: T. Mansour et A. Vainshtein, Restricted 132-avoiding permutations, ADV APPL MA, 26(3), 2001, pp. 258-269

Authors: Richard, N Salomon, H Oliveira, M Rando, R Mansour, T Gu, ZX Wainberg, MA

Citation: N. Richard et al., Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC, ANTIVIR CHE, 11(6), 2000, pp. 359-365

Authors: Richard, N Salomon, H Rando, R Mansour, T Bowlin, TL Wainberg, MA

Citation: N. Richard et al., Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2 '-deoxy-3 '-oxa-4 '-thio-5-fluorocytidine, ANTIM AG CH, 44(5), 2000, pp. 1127-1131

Authors: Richard, N Quan, YD Salomon, H Hsu, M Bedard, J Harrigan, PR Rando, R Mansour, T Bowlin, TL Wainberg, MA

Citation: N. Richard et al., Selection and characterization of HIV-1 variants resistant to the (+) and (-) enantiomers of 2 '-deoxy-3 '-oxa-4 '-thiocytidine (dOTC), ANTIVIR TH, 4(3), 1999, pp. 171-177

Authors: de Muys, JM Gourdeau, H Nguyen-Ba, N Taylor, DL Ahmed, PS Mansour, T Locas, C Richard, N Wainberg, MA Rando, RF

Citation: Jm. De Muys et al., Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2 '-deoxy-3 '-oxa-4 '-thiocytidine, ANTIM AG CH, 43(8), 1999, pp. 1835-1844